Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis.

Edoardo Lenci,Giulia Marcantognini,Valeria Cognigni,Alessio Lupi,Silvia Rinaldi,Luca Cantini,Ilaria Fiordoliva, Anna Lisa Carloni,Marco Rocchi,Lina Zuccatosta,Stefano Gasparini,Rossana Berardi

Exploration of targeted anti-tumor therapy（2021）

引用 1|浏览2

暂无评分

摘要

This study underlines the negative prognostic impact of specific metastatic sites, presence of NMD and extrathoracic disease in advanced NSCLC patients treated with immunotherapy. However, TB does not appear to affect the outcome of these patients.

查看译文

关键词

Immunotherapy,non-small cell lung cancer,tumor burden

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要